Onionin A inhibits ovarian cancer progression by suppressing cancer cell proliferation and the protumour function of macrophages

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Tsuboki, Junko ^a   Fujiwara, Yukio ^a   Horlad, Hasita ^a   Shiraishi, Daisuke ^a   Nohara, Toshihiro ^b   Tayama, Shingo ^a   Motohara, Takeshi ^a   Saito, Yoichi ^a   Ikeda, Tsuyoshi ^b   Takaishi, Kiyomi ^a   Tashiro, Hironori ^c   Yonemoto, Yukihiro ^c   Katabuchi, Hidetaka ^a   Takeya, Motohiro ^a   Komohara, Yoshihiro ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b SOJO UNIVERSITY   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKINE; ONIONIN A; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN; SULFOXIDE; THIOPHENE DERIVATIVE;

ANIMAL; APOPTOSIS; C57BL MOUSE; CELL PROLIFERATION; DISEASE EXACERBATION; DRUG EFFECT; FEMALE; HUMAN; MACROPHAGE; METABOLISM; OVARY TUMOR; SURVIVAL RATE; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOKINES; DISEASE PROGRESSION; FEMALE; HUMANS; MACROPHAGES; MICE, INBRED C57BL; OVARIAN NEOPLASMS; STAT3 TRANSCRIPTION FACTOR; SULFOXIDES; SURVIVAL RATE; THIOPHENES;

EID: 84978419850     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep29588     Document Type: Article

References (28)

1. Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2013. CA Cncer J Clin. 63, 11-30 (2013).
2. Hagemann, T. et al. Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. J Immunol. 176, 5023-5032 (2006).
3. Mantovani, A., Schioppa, T., Porta, C., Allavena, P. & Sica, A. Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metast Rev. 25, 315-322 (2006).
4. Sica, A. & Mantovani, A. Macrophage fusion cuisine. Blood. 114, 4609-4610 (2009).
5. Lewis, C. E. & Pollard, J. W. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 66, 605-612 (2006).
6. Takaishi, K. et al. Involvement of M2-polarized macrophages in the ascites from advanced epithelial ovarian carcinoma in tumor progression via Stat3 activation. Cancer Sci. 101, 2128-2136 (2010).
7. Kawamura, K., Komohara, Y., Takaishi, K., Katabuchi, H. & Takeya, M. Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors. Pathol Int. 59, 300-305 (2009).
8. Yu, H., Kortylewski, M. & Pardoll, D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev. Immunol. 7, 41-51 (2007).
9. Yu, H., Pardoll, D. & Jove, R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 9, 798-809 (2009).
10. Komohara, Y., Jinushi, M. & Takeya, M. Clinical significance of macrophage heterogeneity in human malignant tumors. Cancer Sci. 105, 1-8 (2014).
11. Pollard, J. W. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 4, 71-78 (2004).
12. Pollard, J. W. Trophic macrophages in development and disease. Nat Rev Immunol. 9, 259-270 (2009).
13. Joyce, J. A. & Pollard, J. W. Microenvironmental regulation of metastasis. Nat Rev Cancer. 9, 239-252 (2009).
14. Noy, R. & Pollard, J. W. Tumor-associated macrophages: from mechanisms to therapy. Immunity. 41, 49-61 (2014).
15. Fujiwara, Y., Komohara, Y., Ikeda, T. & Takeya, M. Corosolic acid inhibits glioblastoma cell proliferation by suppressing the activation of signal transducer and activator of transcription-3 and nuclear factor-kappa B in tumor cells and tumor-associated macrophages. Cancer Sci. 102, 206-211 (2011).
16. Horlad, H. et al. Corosolic acid impairs tumor development and lung metastasis by inhibiting the immunosuppressive activity of myeloid-derived suppressor cells. Mol Nutr Food Res. 57, 1046-1054 (2013).
17. Fujiwara, Y. et al. Corosolic acid enhances the antitumor effects of chemotherapy on epithelial ovarian cancer by inhibiting signal transducer and activator of transcription 3 signaling. Oncol Lett. 6, 1619-1623 (2013).
18. Fujiwara, Y. et al. Oleanolic acid inhibits macrophage differentiation into the M2 phenotype and glioblastoma cell proliferation by suppressing the activation of STAT3. Oncol Rep. 26, 1533-1537 (2011).
19. Fujiwara, Y., Takeya, M. & Komohara, Y. A novel strategy for inducing the antitumor effects of triterpenoid compounds: blocking the protumoral functions of tumor-associated macrophages via STAT3 inhibition. BioMed Res Int. 2014, 348539 (2014).
20. El-Aasr, M. et al. Onionin A from Allium cepa inhibits macrophage activation. J Nat Prod. 73, 1306-1308 (2010).
21. Chou, Ting-Chao Frequently asked questions in drug combinations and the mass-action law-based answers. Synergy 1, 3-21 (2014).
22. Biswas, S. K., Sica, A. & Lewis, C. E. Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J Immunol. 180, 2011-2017 (2008).
23. Rosen, D. G. et al. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis. Cancer 107, 2730-2740 (2006).
24. Wen, W. et al. Targeting JAK1/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancer. Mol Cancer Ther. 13, 3037-3048 (2014).
25. Abubaker, K. et al. Targeted disruption of the JAK2/STAT3 pathway in combination with systemic administration of paclitaxel inhibits the priming of ovarian cancer stem cells leading to a reduced tumor burden. Front Oncol. 4, 75 (2014).
26. Latifi, A. et al. Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors. PLoS One. 7, e46858 (2012).
27. Motohara, T. et al. Transient depletion of p53 followed by transduction of c-Myc and K-Ras converts ovarian stem-like cells into tumor-initiating cells. Carcinogenesis. 32, 1597-1606 (2011).
28. Komohara, Y., Ohnishi, K., Kuratsu, J. & Takeya, M. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol. 216, 15-24 (2008).